1800 244 735

Helpline (02) 9874 9777

We are recruiting Board Members

Could you become a Board Member of Huntington’s NSW ACT? Or even the Chairperson?

With our sister organisations in Canada, the UK and some parts of North America, Huntington’s NSW started as a small group of people in the mid-1970s who were determined to bring Huntington’s disease (HD) “Out of the Darkness”, to bring together isolated families and advocate for their needs. We added the ACT to our organisation in 2017.

In 2020 we are facing a different set of challenges, not to mention a worldwide pandemic. There are now many kinds of services and we’ve come a long way. But as anyone from a HD family knows, there is still so much more that could be done to support people in their everyday lives and to raise awareness of this still misunderstood disease.

Our Association is currently recruiting three Board Members and also a new Chairperson as the incumbent is retiring after many years of dedicated service. We are looking for people who are passionate about helping our organisation better serve the HD community. To do this, we need to remain financially viable in a very difficult time for not-for-profit organisations like ourselves.

Experience in fund-raising, financial management or previous Board experience is desirable, but we are mostly looking for hard-working people who will use their experience to help the Association achieve its goals. You can find more specific details of the roles in the Position Descriptions of both Chairperson and Board Member. (Click on the relevant words in the previous sentence to download these.)

In brief:

The Board meets 9-10 times per year, mostly monthly, currently on the 2nd Tuesday evening of the month. Our CEO circulates items for the meeting, and it is expected that you will have read the documents prior to the meeting, in order to contribute. In our Board meetings we aim to create a congenial atmosphere while getting through the many tasks as efficiently as we can.

This role is unpaid, but current and former Board members will agree that their experience has given them great satisfaction. Please consider coming to join us.

Contact:              Lewis Kaplan, CEO, to discuss the organisation and the roles

Mobile:                0407 108 667

Deadline:             23 September with CV and brief covering letter

Send to:               lewis.kaplan@huntingtonsnsw.org.au

 

Share on facebook
Share on twitter
Share on pinterest
Share on email

Latest News and Stories

A 4000km cycle to Broome

Published date: 19 April, 2021

Erica and Bill are about to set off on a cycle to Broome. Erica will be the support driver for her partner Bill as they cover over 4000km to reach Broome in June. We are so grateful that you have chosen to fundraise for us.

OUR SUBMISSION to the Joint Standing Committee on the NDIS inquiry into Independent Assessments

Published date: 6 April, 2021

Huntington’s Associations in NSW/ACT, QLD, WA, SA/NT and TAS have partnered with other groups representing people with various neurological diseases to make a joint submission to the Joint Standing Committee on the National Disability Insurance Scheme inquiry into independent assessments under the NDIS. In summary, we do not support the introduction of independent assessments in ... Read more

WAVE PRECISION-HD clinical trials stopped

Published date: 6 April, 2021

An open letter to the Australian Huntington’s community following the 29 March 2021 press release from Wave Life Sciences: On March 29, 2021, Wave Life Sciences issued a press release regarding their PRECISION-HD clinical trials, which are ongoing in Australia and several other countries globally. The key information from the press release is that for ... Read more

An Open Letter to the Australian Huntington’s Community

Published date: 25 March, 2021

Since the news from Roche came out, Australian clinicians, state organisation leaders, and Huntington’s researchers have been meeting on teleconferences to discuss what this means for the Australian Huntington’s disease community.

Generation HD1 trial halted

Published date: 23 March, 2021

The Roche clinical trial called Phase III Generation HD1 has been halted, not by Roche, but by an independent data monitoring committee.

HD Spotlight on Robyn Russell

Published date: 22 March, 2021

Huntington's NSW ACT Board Member and Chair of the Community Advisory Committee shares her story with us. Read more here.